+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Drug Testing Market By Drug Type, By Sample Type, By Product Type, By End User, By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

  • ID: 5387585
  • Report
  • June 2021
  • Region: Asia Pacific
  • 111 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Abbott Laboratories
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Omega Laboratories, Inc.
  • Quidel Corporation
  • MORE
The Asia Pacific Drug Testing Market is expected to witness market growth of 6.9% CAGR during the forecast period (2021-2027).

Maintaining a secure and efficient work environment is crucial for businesses and employees. The growth of the APAC region is expected to be bolstered by the increasing drug & alcohol consumption, the imposition of strict mandating drug and alcohol testing, government investment in key markets, and regulatory approvals and product and services launches. The emerging drug abuse in India appears from the recent rapid economic development. Moreover, millions of Indians are significantly dependent on alcohol, opiates, cannabis, and drug misuse is highly prevalent in the country. In addition to it, drug abuse cases are increasing in this country which is putting an inordinate burden on the healthcare systems. Therefore, a need has been felt over the years for some effective drug testing regulations in order to reduce the cases and subsequently deliver the appropriate treatment.

Due to the outbreak of the COVID-19 pandemic, fingerprint-based drug testing is a comparatively new concept that has gained high popularity in recent years. The COVID-19 pandemic has made it hard to perform drug testing in labs, hospitals, and other facilities due to the possibility of transmission of the infection. Fingerprint-based drug testing can assist in curbing the spread of COVID-19 as it is non-invasive, less time-taking, hygienic, facilitates social distancing, user-friendly, portable, and needs no particular preparation for sample collection and handling. This test has extremely easy usage at any place and anytime, thereby providing flexible and efficient workplace drug testing. The test examines small traces of sweat in the fingerprint to identify the drug and drug metabolites. If this test is broadly accepted, it is expected to substitute hair, urine, and blood-based drug tests. This is the main opportunity for the key market players to capitalize on in the global drug screening market.

The China market dominated the Asia Pacific Rapid Testing Devices Drug Testing Market by Country 2020, thereby, achieving a market value of $80.8 million by 2027. The Japan market is exhibiting a CAGR of 7.9% during (2021 - 2027). Additionally, The India market is anticipated to witness a CAGR of 9.1% during (2021 - 2027).

Based on Drug Type, the market is segmented into Cannabis/Marijuana, Opioids, Cocaine, Alcohol, Amphetamine & Methamphetamine, LSD and Others. Based on Sample Type, the market is segmented into Urine Samples, Oral Fluid Samples, Hair Samples and Other Samples. Based on Product Type, the market is segmented into Consumables, Instruments, Rapid Testing Devices and Services. Based on End User, the market is segmented into Drug Testing Laboratories, Workplaces, Hospitals and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Siemens AG (Siemens Healthineers), Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Dragerwerk AG & Co. KGaA, Quidel Corporation, and Omega Laboratories, Inc.

Scope of the Study

Market Segments covered in the Report:

By Drug Type
  • Cannabis/Marijuana
  • Opioids
  • Cocaine
  • Alcohol
  • Amphetamine & Methamphetamine
  • LSD
  • Others
By Sample Type
  • Urine Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Samples
By Product Type
  • Consumables
  • Instruments
  • Rapid Testing Devices
  • Services
By End User
  • Drug Testing Laboratories
  • Workplaces
  • Hospitals
  • Others
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
Companies Profiled
  • Quest Diagnostics, Incorporated
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Siemens AG (Siemens Healthineers)
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Dragerwerk AG & Co. KGaA
  • Quidel Corporation
  • Omega Laboratories, Inc.
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Omega Laboratories, Inc.
  • Quidel Corporation
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Drug Testing Market, by Drug Type
1.4.2 Asia Pacific Drug Testing Market, by Sample Type
1.4.3 Asia Pacific Drug Testing Market, by Product Type
1.4.4 Asia Pacific Drug Testing Market, by End User
1.4.5 Asia Pacific Drug Testing Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Drug Testing Market by Drug Type
3.1 Asia Pacific Cannabis/Marijuana Drug Testing Market by Country
3.2 Asia Pacific Opioids Drug Testing Market by Country
3.3 Asia Pacific Cocaine Drug Testing Market by Country
3.4 Asia Pacific Alcohol Drug Testing Market by Country
3.5 Asia Pacific Amphetamine & Methamphetamine Drug Testing Market by Country
3.6 Asia Pacific LSD Drug Testing Market by Country
3.7 Asia Pacific Other Drug Type Drug Testing Market by Country

Chapter 4. Asia Pacific Drug Testing Market by Sample Type
4.1 Asia Pacific Drug Testing Urine Samples Market by Country
4.2 Asia Pacific Drug Testing Oral Fluid Samples Market by Country
4.3 Asia Pacific Drug Testing Hair Samples Market by Country
4.4 Asia Pacific Drug Testing Other Samples Market by Country

Chapter 5. Asia Pacific Drug Testing Market by Product Type
5.1 Asia Pacific Consumables Drug Testing Market by Country
5.2 Asia Pacific Instruments Drug Testing Market by Country
5.3 Asia Pacific Rapid Testing Devices Drug Testing Market by Country
5.4 Asia Pacific Services Drug Testing Market by Country

Chapter 6. Asia Pacific Drug Testing Market by End-use
6.1 Asia Pacific Drug Testing Laboratories Drug Testing Market by Country
6.2 Asia Pacific Workplaces Drug Testing Market by Country
6.3 Asia Pacific Hospitals Drug Testing Market by Country
6.4 Asia Pacific Others Drug Testing Market by Country

Chapter 7. Asia Pacific Drug Testing Market by Country
7.1 China Drug Testing Market
7.1.1 China Drug Testing Market by Drug Type
7.1.2 China Drug Testing Market by Sample Type
7.1.3 China Drug Testing Market by Product Type
7.1.4 China Drug Testing Market by End-use
7.2 Japan Drug Testing Market
7.2.1 Japan Drug Testing Market by Drug Type
7.2.2 Japan Drug Testing Market by Sample Type
7.2.3 Japan Drug Testing Market by Product Type
7.2.4 Japan Drug Testing Market by End-use
7.3 India Drug Testing Market
7.3.1 India Drug Testing Market by Drug Type
7.3.2 India Drug Testing Market by Sample Type
7.3.3 India Drug Testing Market by Product Type
7.3.4 India Drug Testing Market by End-use
7.4 South Korea Drug Testing Market
7.4.1 South Korea Drug Testing Market by Drug Type
7.4.2 South Korea Drug Testing Market by Sample Type
7.4.3 South Korea Drug Testing Market by Product Type
7.4.4 South Korea Drug Testing Market by End-use
7.5 Singapore Drug Testing Market
7.5.1 Singapore Drug Testing Market by Drug Type
7.5.2 Singapore Drug Testing Market by Sample Type
7.5.3 Singapore Drug Testing Market by Product Type
7.5.4 Singapore Drug Testing Market by End-use
7.6 Malaysia Drug Testing Market
7.6.1 Malaysia Drug Testing Market by Drug Type
7.6.2 Malaysia Drug Testing Market by Sample Type
7.6.3 Malaysia Drug Testing Market by Product Type
7.6.4 Malaysia Drug Testing Market by End-use
7.7 Rest of Asia Pacific Drug Testing Market
7.7.1 Rest of Asia Pacific Drug Testing Market by Drug Type
7.7.2 Rest of Asia Pacific Drug Testing Market by Sample Type
7.7.3 Rest of Asia Pacific Drug Testing Market by Product Type
7.7.4 Rest of Asia Pacific Drug Testing Market by End-use

Chapter 8. Company Profiles
8.1 Quest Diagnostics, Incorporated
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Recent strategies and developments:
8.1.2.1 Partnerships, Collaborations, and Agreements:
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 F. Hoffmann-La Roche Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Thermo Fisher Scientific, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Siemens AG (Siemens Healthineers)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Agilent Technologies, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.8 Dragerwerk AG & Co. KGaA
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Quidel Corporation
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Trials & Approvals:
8.10. Omega Laboratories, Inc.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
8.10.2.2 Accreditation:
Note: Product cover images may vary from those shown
  • Quest Diagnostics, Incorporated
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Siemens AG (Siemens Healthineers)
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Dragerwerk AG & Co. KGaA
  • Quidel Corporation
  • Omega Laboratories, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll